Expert input on melasma treatment choices
Part of Skin clinical trials.
This study gathers expert dermatologists to create guidelines for managing melasma, a skin condition that causes dark patches. If you are an experienced dermatologist, your opinion could help shape future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a board-certified or equivalent dermatologist
- You have at least 5 years of experience treating melasma after your certification
- You are willing to participate in all rounds of the Delphi survey
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This trial tests a microneedling technique combined with three topical medications (metformin, tranexamic acid, and a modified Kligman's formula) to treat melasma, a common skin condition causing dark patches. The goal is to see if this approach safely and effectively reduces melasma in eligible women.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.